Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anandan Palani

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Bioorganic & Medicinal Chemistry Letters|December 21, 2011
Facile synthesis of tetracyclic azepine and oxazocine derivatives and their potential as MAPKAP-K2 (MK2) inhibitorsAshwin U Rao, Dong Xiao, Xianhai Huang, et al.
Bioorganic & Medicinal Chemistry Letters|February 14, 2012
Synthesis and structure-activity relationship (SAR) study of 4-azabenzoxazole analogues as H3 antagonistsNing Shao, Robert Aslanian, Robert E West, et al.
Journal of Medicinal Chemistry|June 28, 2002
Synthesis, SAR, and biological evaluation of oximino-piperidino-piperidine amides. 1. Orally bioavailable CCR5 receptor antagonists with potent anti-HIV activityAnandan Palani, Sherry Shapiro, Hubert Josien, et al.
ACS Medicinal Chemistry Letters|August 18, 2022
Discovery of Insulin/GLP-1/Glucagon Triagonists for the Treatment of Diabetes and ObesityChunhui Huang, Anandan Palani, Zhiqiang Yang, et al.
Bioorganic & Medicinal Chemistry Letters|November 4, 2018
Design and evaluation of novel tetracyclic benzofurans as palm site allosteric inhibitors of HCV NS5B polymeraseHong Liu, Xing Dai, Shuwen He, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2008
Spiro-piperidine azetidinones as potent TRPV1 antagonistsDong Xiao, Anandan Palani, Robert Aslanian, et al.
Bioorganic & Medicinal Chemistry Letters|December 16, 2011
A three-step protocol for lead optimization: quick identification of key conformational features and functional groups in the SAR studies of non-ATP competitive MK2 (MAPKAPK2) inhibitorsXianhai Huang, Xiaohong Zhu, Xiao Chen, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2003
Biological evaluation and interconversion studies of rotamers of SCH 351125, an orally bioavailable CCR5 antagonistAnandan Palani, Sherry Shapiro, John W Clader, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
The Discovery of Pyridone and Pyridazone Heterocycles as γ-Secretase ModulatorsXianhai Huang, Robert Aslanian, Wei Zhou, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a Potent Pyrazolopyridine Series of γ-Secretase ModulatorsJun Qin, Wei Zhou, Xianhai Huang, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry Letters|December 21, 2011
Facile synthesis of tetracyclic azepine and oxazocine derivatives and their potential as MAPKAP-K2 (MK2) inhibitorsAshwin U Rao, Dong Xiao, Xianhai Huang, et al.
Bioorganic & Medicinal Chemistry Letters|February 14, 2012
Synthesis and structure-activity relationship (SAR) study of 4-azabenzoxazole analogues as H3 antagonistsNing Shao, Robert Aslanian, Robert E West, et al.
Journal of Medicinal Chemistry|June 28, 2002
Synthesis, SAR, and biological evaluation of oximino-piperidino-piperidine amides. 1. Orally bioavailable CCR5 receptor antagonists with potent anti-HIV activityAnandan Palani, Sherry Shapiro, Hubert Josien, et al.
ACS Medicinal Chemistry Letters|August 18, 2022
Discovery of Insulin/GLP-1/Glucagon Triagonists for the Treatment of Diabetes and ObesityChunhui Huang, Anandan Palani, Zhiqiang Yang, et al.
Bioorganic & Medicinal Chemistry Letters|November 4, 2018
Design and evaluation of novel tetracyclic benzofurans as palm site allosteric inhibitors of HCV NS5B polymeraseHong Liu, Xing Dai, Shuwen He, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2008
Spiro-piperidine azetidinones as potent TRPV1 antagonistsDong Xiao, Anandan Palani, Robert Aslanian, et al.
Bioorganic & Medicinal Chemistry Letters|December 16, 2011
A three-step protocol for lead optimization: quick identification of key conformational features and functional groups in the SAR studies of non-ATP competitive MK2 (MAPKAPK2) inhibitorsXianhai Huang, Xiaohong Zhu, Xiao Chen, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2003
Biological evaluation and interconversion studies of rotamers of SCH 351125, an orally bioavailable CCR5 antagonistAnandan Palani, Sherry Shapiro, John W Clader, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
The Discovery of Pyridone and Pyridazone Heterocycles as γ-Secretase ModulatorsXianhai Huang, Robert Aslanian, Wei Zhou, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a Potent Pyrazolopyridine Series of γ-Secretase ModulatorsJun Qin, Wei Zhou, Xianhai Huang, et al.
Pageof 6